Sorafenib-Induced Hepatocellular Carcinoma Cell Death Depends on Reactive Oxygen Species Production In Vitro and In Vivo

R Coriat, C Nicco, C Chéreau, O Mir, J Alexandre… - Molecular cancer …, 2012 - AACR
Sorafenib is presently the only effective therapy in advanced hepatocellular carcinoma
(HCC). Because most anticancer drugs act, at least in part, through the generation of …

Sorafenib-induced hepatocellular carcinoma cell death depends on reactive oxygen species production in vitro and in vivo

R Coriat, C Nicco, C Chéreau, O Mir… - Molecular Cancer …, 2012 - hero.epa.gov
Sorafenib is presently the only effective therapy in advanced hepatocellular carcinoma
(HCC). Because most anticancer drugs act, at least in part, through the generation of …

[PDF][PDF] Sorafenib-Induced Hepatocellular Carcinoma Cell Death Depends on Reactive Oxygen Species ProductionIn Vitroand

Mol Cancer Ther, 2012 - scholar.archive.org
Sorafenib is presently the only effective therapy in advanced hepatocellular carcinoma
(HCC). Because most anticancer drugs act, at least in part, through the generation of …

Sorafenib-Induced Hepatocellular Carcinoma Cell Death Depends on Reactive Oxygen Species ProductionIn VitroandIn Vivo

R Coriat, C Nicco, C Chéreau, O Mir… - Molecular Cancer …, 2012 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Sorafenib is presently the only effective
therapy in advanced hepatocellular carcinoma (HCC). Because most anticancer drugs act …

Sorafenib-induced hepatocellular carcinoma cell death depends on reactive oxygen species production in vitro and in vivo

R Coriat, C Nicco, C Chéreau, O Mir… - Molecular cancer …, 2012 - pubmed.ncbi.nlm.nih.gov
Sorafenib is presently the only effective therapy in advanced hepatocellular carcinoma
(HCC). Because most anticancer drugs act, at least in part, through the generation of …

Sorafenib-induced hepatocellular carcinoma cell death depends on reactive oxygen species production in vitro and in vivo.

R Coriat, C Nicco, C Chéreau, O Mir… - Molecular Cancer …, 2012 - europepmc.org
Sorafenib is presently the only effective therapy in advanced hepatocellular carcinoma
(HCC). Because most anticancer drugs act, at least in part, through the generation of …